Loading...
Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: What are the risks of waiting?
BACKGROUND: Clinical trials have confirmed that implantable cardioverter defibrillators (ICDs) reduce mortality in patients with a left ventricular ejection fraction below 30%. The ‘real-world’ prognosis before ICD implantation in such patients is not known. The estimated risk of death is 0.8% per m...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Pulsus Group Inc
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2782507/ https://ncbi.nlm.nih.gov/pubmed/19812807 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|